Skip to main content
Clinical Trials/NCT01044511
NCT01044511UnknownNot Applicable

Prospective, Randomized Trial of the Effects on HRQoL, Cost-Utility and Reintervention Rate, of Nurse Home Visits, in Patients With SEMS Treated Malignant Disease in the Esophagus and Cardia.

Michael Bau Mortensen1 site in 1 country80 target enrollmentStarted: January 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
HRQoL, EORTC C-30, EOS-18

Study Overview

Brief Summary

The aim of this study is to compare, specialist nurse home visits in patients with inoperable cancer in the esophagus or cardia, who are palliated with Self Expanding Metal Stent, to standard patient contact with regards to quality of life, number and character of reinterventions and cost-effectiveness.

Detailed Description

The aim of this study is to compare, specialist nurse home visits in patients with inoperable cancer in the esophagus or gastro-esophageal junction (cardia), who are palliated with Self Expanding Metal Stent, to standard patient contact with regards to quality of life, number and character of reinterventions and cost-effectiveness.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Malignant obstruction of esophagus or cardia treated with SEMS due to non-operable disease.

Exclusion Criteria

  • •Mentally unable to fill out questionaire

Arms & Interventions

Home visit

Experimental

After SEMS placement, 2 home visits and a phonecall are made by a specialist nurse

Intervention: Home visits (Behavioral)

Standard

Active Comparator

Standard contact via Hotline and traditional referring methods

Intervention: standard (Behavioral)

Outcomes

Primary Outcomes

HRQoL, EORTC C-30, EOS-18

Time Frame: 2 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Michael Bau Mortensen
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Michael Bau Mortensen

MD, PhD

Odense University Hospital

Study Sites (1)

Loading locations...

Similar Trials